Alpha Cognition Announces Change of Officer

VANCOUVER, British Columbia -- Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, announces that Don Kalkofen has resigned as the Chief Financial Officer of the Company to pursue other opportunities. Read More

Alpha Cognition Announces Change of Officer

Alpha Cognition Announces Change of Officer

Alpha Cognition Announces Change of Officer

Alpha Cognition Announces Change of Officer
Alpha Cognition Announces Change of Officer
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Tiny But Vital Metal Markets Rush to Adjust to Chinese Clampdown

No farm, no problem: Young farmers get their start in the industry in other ways
Green Hydrogen Goes From Hyped to Humbled on Eye-Popping Costs